Physician profile
Benjamin Fano
NPI 1952495400
$458.51
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $100 · 2021: $40.85 · 2023: $20.62 · 2024: $63.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $84.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $84.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $142.20 | 2019-2024 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals Lp | $106.41 | 2019-2024 | Farxiga |
| Melinta Therapeutics, LLC | $45.81 | 2019-2021 | |
| Lilly USA, LLC | $42.01 | 2020-2023 | Mounjaro |
| Strongbridge US INC. | $25.63 | 2020 | |
| Novartis Pharmaceuticals Corporation | $22.87 | 2019 | |
| Astellas Pharma US INC | $22.66 | 2024 | Veozah |
| Medtronic Vascular, INC. | $18.83 | 2020 | |
| Janssen Pharmaceuticals, INC | $17.92 | 2019 | |
| Biogen, INC. | $14.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Fano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.